Related Experiment Video
Updated: Jun 21, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C
S E Behnam1, R Hindiyeh, D J Fife
1Department of Dermatology, University of California, Irvine, CA, USA.
Abstract:
Patients with psoriasis and chronic hepatitis C virus (HCV) infection are a therapeutic challenge. Systemic psoriasis treatment with methotrexate and acitretin can be hepatotoxic, and interferon (IFN)-alpha for treatment of HCV can worsen psoriasis. Etanercept can be successfully used in patients with psoriasis and HCV. To our knowledge, this is the first case report of etanercept used prophylactically to prevent a psoriatic flare in a patient with HCV treated with IFN-alpha and ribavirin.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Viral Hepatitis I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Antiviral Nucleoside Inhibitors
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
